Home » PDUFA Provisions Could Harm FDA and Industry, Expert Says
PDUFA Provisions Could Harm FDA and Industry, Expert Says
August 24, 2007
Some of the provisions in the FDA Revitalization Act, S. 1082 and H.R. 2900, will be ineffective and could cripple the FDA and put unnecessary burdens on pharmaceutical companies, Center for Medicines in the Public Interest President Peter Pitts said.